These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9737650)

  • 1. Importance of beta blockade in the therapy of serious ventricular arrhythmias.
    Reiter MJ; Reiffel JA
    Am J Cardiol; 1998 Aug; 82(4A):9I-19I. PubMed ID: 9737650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta adrenergic blockade in the treatment of sustained ventricular tachycardia or ventricular fibrillation.
    Wiesfeld AC; Crijns HJ; Tuininga YS; Lie KI
    Pacing Clin Electrophysiol; 1996 Jul; 19(7):1026-35. PubMed ID: 8823828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-arrhythmia agents in the therapy of ventricular arrhythmias in the post-CAST era].
    Candinas R; Bauersfeld U
    Schweiz Med Wochenschr; 1994 Sep; 124(35):1545-9. PubMed ID: 7939521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of ventricular arrhythmias.
    Aronow WS
    Compr Ther; 2008; 34(2):89-99. PubMed ID: 18833785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radiofrequency ablation as acute treatment of ventricular arrhythmia].
    Emerek K; Riahi S; Hjortshøj SP
    Ugeskr Laeger; 2013 Jan; 175(1-2):48-51. PubMed ID: 23305641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons from antiarrhythmic trials involving class III antiarrhythmic drugs.
    Yap YG; Camm AJ
    Am J Cardiol; 1999 Nov; 84(9A):83R-89R. PubMed ID: 10568665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empiric therapy with beta-blockers.
    Hjalmarson A
    Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 2):460-6. PubMed ID: 7513874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
    Lazzara R
    Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.
    Exner DV; Reiffel JA; Epstein AE; Ledingham R; Reiter MJ; Yao Q; Duff HJ; Follmann D; Schron E; Greene HL; Carlson MD; Brodsky MA; Akiyama T; Baessler C; Anderson JL
    J Am Coll Cardiol; 1999 Aug; 34(2):325-33. PubMed ID: 10440140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of ventricular arrhythmias in older patients after CAST.
    Aronow WS
    Drugs Aging; 1995 Feb; 6(2):112-24. PubMed ID: 7711358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blocking agents vs. antiarrhythmic interventions in heart failure complicated by arrhythmias.
    Meinertz T; Hofmann T; Zehender M; Drexler H; Hohnloser S; Just H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S151-7. PubMed ID: 11527120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
    Alboni P
    Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
    Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
    N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the pharmacologic treatment of ventricular arrhythmias.
    Schleifer JW; Sorajja D; Shen WK
    Expert Opin Pharmacother; 2015; 16(17):2637-51. PubMed ID: 26513538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving role of sotalol in the management of ventricular tachyarrhythmias.
    O'Callaghan PA; McGovern BA
    Am J Cardiol; 1996 Aug; 78(4A):54-60. PubMed ID: 8780329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter-defibrillators.
    Aronow WS
    Am J Ther; 2010; 17(6):e208-20. PubMed ID: 19918166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug therapy of ventricular arrhythmias].
    Hohnloser SH
    Med Klin (Munich); 1997 Apr; 92(4):208-10. PubMed ID: 9221302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.